, Consulting fees from Merck
HAC-pharma; SD has served as a speaker, consultant, and advisory board member for Schering-Plough ,
Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort, Gastroenterology, vol.139, pp.1147-55, 2010. ,
, Inflamm Bowel Dis, vol.17, pp.1415-1437, 2011.
,
Development of the Lemann index to assess digestive tract damage in patients with Crohn's disease, Gastroenterology, vol.148, p.3, 2015. ,
Bowel Damage as Assessed by the Lemann Index is Reversible on Anti-TNF Therapy for Crohn's Disease, J Crohns Colitis, vol.9, pp.633-642, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01667769
,
Development of the Paris definition of early Crohn's disease for diseasemodification trials: results of an international expert opinion process, Am J Gastroenterol, vol.107, pp.1770-1776, 2012. ,
Catching the therapeutic window of opportunity in early Crohn's disease, Curr Drug Targets, vol.15, pp.1056-63, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01687387
Early Crohn disease: a proposed definition for use in disease-modification trials, Gut, vol.59, pp.141-148, 2010. ,
Changes in the Lemann Index Values During the First Years of Crohn's Disease, Clin Gastroenterol Hepatol, vol.13, p.3, 2015. ,
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease, Aliment Pharmacol Ther, vol.42, pp.977-89, 2015. ,
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease, Gut, vol.58, pp.1113-1133, 2009. ,
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, vol.17, pp.1759-68, 2011. ,
Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics, Gut, vol.64, pp.1397-402, 2015. ,
Modelling survival data in medical research, 1994. ,
Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, vol.81, pp.515-526, 1994. ,
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis, J Crohns Colitis, vol.4, pp.7-27, 2010. ,
Preventing Collateral Damage in Crohn's Disease: The Lemann Index, J Crohns Colitis, vol.10, pp.495-500, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01665013
,
, Long-term evolution of disease behavior of Crohn's disease, Inflamm Bowel Dis, vol.8, pp.244-50, 2002.
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey, J Crohns Colitis, vol.1, pp.10-20, 2007. ,
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease, Inflamm Bowel Dis, vol.18, pp.496-505, 2012. ,
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate, Am J Gastroenterol, vol.108, pp.1744-53, 2013. ,
,
Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative, J Crohns Colitis, vol.9, pp.601-607, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01668612
,
Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease, Am J Gastroenterol, 2016. ,